SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.
Ahmed ElkharsawiUlrike von ArnimRenate SchmelzCornelia SanderAndreas StallmachNiels TeichJens WalldorfPhilipp Alexander ReukenPublished in: Zeitschrift fur Gastroenterologie (2022)
Vaccination against SARS-CoV-2 is safe in IBD patients. These results may help to reduce fears regarding the vaccination in IBD patients. Our results can help to reduce fears in IBD patients regarding the SARS-CoV-2 vaccine. A close communication between patients and physicians before and after the vaccination may be beneficial.